Marjorie Montanez-Wiscovich, M.D., Ph.D., FAAD
Clinical Associate Professor
Department:
MD-DERMATOLOGY
Business Phone:
(352) 594-1500
About Marjorie Montanez-Wiscovich
Dr. Marjorie Montanez-Wiscovich is a faculty member in the University Florida Department of Dermatology and UF Health physician. She was born and raised in Puerto Rico. She obtained her medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio, and stayed in Cleveland to complete her residency in dermatology at MetroHealth Medical Center.
Dr. Montanez-Wiscovich’s research has been the feature of multiple publications and she has been the recipient of several honors and awards including AAAS/Science Program for Excellence in Science member and the Diversity Award at the MSTP Annual Student Conference. She is a member of the American Contact Dermatitis Society, the American Medical Association, the American Academy of Dermatology and the Association of Professors of Dermatology. She is bilingual and speaks both English and Spanish.
Accomplishments
Presidential Citation Award for significant contributions to the Society and the field of contact dermatitis
2021
·
American Contact Dermatitis Society
Bryan R. Davis Award for Excellence in Resident Education, Department of Dermatology
2018
·
MetroHealth Medical Center
Teaching Faculty of the Year Award, Department of Family Medicine
2018
·
MetroHealth Medical Center
Diversity Award
2009
·
MSTP Annual Student Conference
Travel Award
2009
·
MSTP Annual Student Conference
Honorable Mention
2008
·
Research ShowCASE
Excellence in Science Member
2007
·
AAAS/Science Program
Board Certifications
-
DermatologyAmerican Board of Dermatology
Clinical Profile
Specialties
- Dermatology
Areas of Interest
- Contact dermatitis
- Psoriasis
Publications
Academic Articles
2025
A case of primary cutaneous marginal zone lymphoma in a 12-year-old with mast cell activating syndrome.
Pediatric blood & cancer.
72(1)
[DOI] 10.1002/pbc.31381.
[PMID] 39394971.
2024
A propensity-matched study of psoriasis and migraine in a nationally diverse cohort.
Clinical and experimental dermatology.
49(8):913-915
[DOI] 10.1093/ced/llae059.
[PMID] 38369778.
2024
From the Cochrane Library: Lifestyle changes for treating psoriasis.
Journal of the American Academy of Dermatology.
90(1):e35-e37
[DOI] 10.1016/j.jaad.2023.09.023.
[PMID] 37717729.
2024
Genetic association of maternal smoking around birth with psoriasis: A two-sample Mendelian randomization analysis.
Journal of the European Academy of Dermatology and Venereology : JEADV.
[DOI] 10.1111/jdv.20410.
[PMID] 39569873.
2024
Hypoxic transcriptomes predict survival and tumor-infiltrating immune cell composition in cutaneous melanoma.
Melanoma research.
34(2):118-124
[DOI] 10.1097/CMR.0000000000000938.
[PMID] 38329217.
2024
Measuring internalized health-related stigma across health conditions: development and validation of the I-HEARTS Scale.
BMC medicine.
22(1)
[DOI] 10.1186/s12916-024-03661-z.
[PMID] 39379928.
2024
Multiple Eruptive Keratoacanthomas Secondary to Nivolumab Immunotherapy.
Journal of immunotherapy (Hagerstown, Md. : 1997).
47(3):98-100
[DOI] 10.1097/CJI.0000000000000498.
[PMID] 38009069.
2024
Patient satisfaction with teledermatology: A systematic review and meta-analysis.
Journal of the American Academy of Dermatology.
91(6):1288-1289
[DOI] 10.1016/j.jaad.2024.07.1526.
[PMID] 39218356.
2024
Psoriasis and non-Hodgkin’s lymphoma in a diverse sample of U.S. adults: a propensity matched case-control study.
Journal of the American Academy of Dermatology.
91(1):104-107
[DOI] 10.1016/j.jaad.2024.02.040.
[PMID] 38452818.
2023
Athena: Specialty Certificate Examination Case for general dermatology and dermatology in primary healthcare.
Clinical and experimental dermatology.
48(6):712-713
[DOI] 10.1093/ced/llad092.
[PMID] 36899478.
2023
Cutaneous Ovarian Carcinoma Metastases: Case Report and Literature Review.
Cureus.
15(8)
[DOI] 10.7759/cureus.44459.
[PMID] 37791206.
2023
Factors influencing inpatient hospitalization for hidradenitis suppurativa: a retrospective cohort study of 59,100 ED visits (2015-2019).
Archives of dermatological research.
315(10):2999-3001
[DOI] 10.1007/s00403-023-02728-w.
[PMID] 37796340.
2023
Identification of three master regulatory genes with prognostic value for uveal melanoma by means of weighted co-expression network analysis.
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI).
29(7)
[DOI] 10.1111/srt.13358.
[PMID] 37522506.
2022
American Contact Dermatitis Society Position Statement: Dermatitis and Skin of Color.
Dermatitis : contact, atopic, occupational, drug.
33(1):3-9
[DOI] 10.1097/DER.0000000000000840.
[PMID] 35029346.
2022
Dupilumab-Associated Head and Neck Dermatitis With Ocular Involvement in a Ten-Year-Old With Atopic Dermatitis: A Case Report and Review of the Literature.
Cureus.
14(7)
[DOI] 10.7759/cureus.27170.
[PMID] 36017279.
2021
Allergic Contact Dermatitis Due to Thiourea Derivatives in a Gun Holster.
Dermatitis : contact, atopic, occupational, drug.
32(4):e64-e66
[DOI] 10.1097/DER.0000000000000664.
[PMID] 33273224.
2021
Ocular pseudopemphigoid with concomitant eyelid dermatitis secondary to rosacea.
JAAD case reports.
7:62-64
[DOI] 10.1016/j.jdcr.2020.11.007.
[PMID] 33354609.
2021
Tumor Necrosis Factor Inhibitor-Induced Eczematous Eruption: A Report of Two Cases and Review of the Literature.
Cureus.
13(5)
[DOI] 10.7759/cureus.15078.
[PMID] 34159000.
2020
Antineutrophil cytoplasmic antibody vasculitis induced by hydralazine.
Cutis.
105(1):E32-E35
[PMID] 32074164.
2020
Dermatology leadership and a top-down approach to increasing diversity.
Clinics in dermatology.
38(3):316-320
[DOI] 10.1016/j.clindermatol.2020.02.006.
[PMID] 32563343.
2020
Recalcitrant erosive plaques on the palms and soles: A rare manifestation of eccrine syringofibroadenoma.
JAAD case reports.
6(7):590-592
[DOI] 10.1016/j.jdcr.2020.05.004.
[PMID] 32685646.
2019
Eosinophilic folliculitis in a patient with chronic myelomonocytic leukemia.
JAAD case reports.
5(8):656-659
[DOI] 10.1016/j.jdcr.2019.05.021.
[PMID] 31388531.
2019
Evaluation and Management of the Patient with Pruritus
SN Comprehensive Clinical Medicine.
1(10):797-805
[DOI] 10.1007/s42399-019-00137-7.
2019
Verrucous psoriasis treated with methotrexate and acitretin combination therapy.
Cutis.
104(6):E10-E12
[PMID] 31939936.
2018
Pediatric Baseline Patch Test Series: Pediatric Contact Dermatitis Workgroup.
Dermatitis : contact, atopic, occupational, drug.
29(4):206-212
[DOI] 10.1097/DER.0000000000000385.
[PMID] 29933256.
2010
Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells.
The Journal of pathology.
222(3):271-81
[DOI] 10.1002/path.2762.
[PMID] 20814902.
2009
LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.
Oncogene.
28(41):3608-18
[DOI] 10.1038/onc.2009.221.
[PMID] 19648968.
2005
Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
Oncogene.
24(33):5173-90
[PMID] 15897883.
Grants
May 2024
– Nov 2024
The American Academy of Dermatology Actinic Keratosis Measures Testing Participation Agreement
Role: Principal Investigator
Funding: AM ACAD OF DERMATOLOGY
Apr 2023
ACTIVE
An Open-Label, Single-Arm, Phase 4 Study of Ruxolitinib Cream in Adults with Atopic Dermatitis Experiencing Sleep Disturbance in the United States (Morpheus)
Role: Principal Investigator
Funding: PREMIER RESEARCH INTERNATIONAL
via INCYTE CORPORATION
Mar 2023
– Feb 2024
THE AMERICAN ACADEMY OF DERMATOLOGY PSORIASIS MEASURES TESTING PARTICIPATION AGREEMENT
Role: Principal Investigator
Funding: AM ACAD OF DERMATOLOGY
Apr 2021
– Jun 2023
Interdisciplinary Dermatitis Fellowship
Role: Principal Investigator
Funding: PFIZER INC
Sep 2019
– Aug 2023
A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of KPL 716 in Reducing Pruritus in Subjects with Prurigo Nodularis
Role: Principal Investigator
Funding: INNOVADERM RESEARCH
via KINIKSA PHARMACEUTICALS
Jan 2019
ACTIVE
Corrona Psoriasis (PSO) Registry
Role: Principal Investigator
Funding: COREVITAS
Education
Residency – Dermatology
2011-2015
·
MetroHealth Medical Center
Internship – Internal Medicine
2011-2012
·
University Hospitals of Cleveland
Medical School
2007-2011
·
Case Western Reserve University
Contact Details
Phones:
- Business:
- (352) 594-1500
Addresses:
- Business Mailing:
-
PO Box 100279
GAINESVILLE FL 32610 - Business Street:
-
4037 NW 86TH TER
GAINESVILLE FL 32606